Sector: MedicalVANDA PHARMACEUTICAL (NASDAQ: VNDA)
Headlines
- Semi-Annual Changes to the NASDAQ Biotechnology Index
Nov 13, 2009 08:02 PM | CSKI, HITK, NDAQ, PARD, SIGA, SPPI
- Vanda Pharmaceuticals Reports Third Quarter 2009 Results
Nov 02, 2009 07:01 AM | VNDA
- Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
Oct 28, 2009 07:00 PM | VNDA
- More New 2009 Highs!
Oct 19, 2009 08:27 PM | ACOR, AIG, GS, NTRI, RMBS
- RidgewaterEquity.com Free Fundamental Sector & Market Research on THOR, VNDA, SIGM, ETRM, TXRH and NFLX
Oct 19, 2009 06:29 AM | ETRM, SIGM, THOR, VNDA
- Blue Chips Continue Rally, But Nasdaq 100 Lags
Oct 15, 2009 06:28 PM | ACOR, DNDN, GS, VNDA
- More New 2009 Index Highs!
Oct 14, 2009 07:31 PM | DNDN, GS, HGSI, INTC, JPM, NTRI
- Dr. Stockpick Announces Daily Stock Watch - VASC, VNDA, DARA
Oct 13, 2009 07:55 PM | NVS, VASC, VNDA
- FDA Calendar Extreme Trades: 85 Single Digit Stocks
Oct 13, 2009 12:34 PM | ACCP, APOL, CLDA, CRI, CRL, CYTX
- Novartis Agrees To Market Vanda's Fanapt, But Where Does That Leave Titan Pharmaceuticals?
Oct 13, 2009 12:37 AM | VFC, VNDA
- Vanda Pharmaceuticals Reports Second Quarter 2009 Results
Aug 10, 2009 06:30 AM | VNDA
- Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
Aug 06, 2009 04:31 PM | VNDA
- BenchmarkJournal.Com Free Analyst Review for PNM, WH, NCR, UNT, VNDA and SCMR
Jul 14, 2009 10:26 AM | NCR, PNM, SCMR, UNT, VNDA, WH
- Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
May 29, 2009 05:30 PM | VNDA
- Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting
May 14, 2009 02:53 PM | VNDA
- Vanda Pharmaceuticals Announces Withdrawal of Director Nominees and Proposal to Liquidate Submitted by Tang Capital
May 07, 2009 09:03 AM | VNDA
- Titan Announces FDA Approval of Fanapt™ (Iloperidone) For the Treatment of Schizophrenia
May 06, 2009 10:24 PM | VNDA
- FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia
May 06, 2009 06:38 PM | VNDA
- Vanda Pharmaceuticals Reports First Quarter 2009 Results
Apr 29, 2009 08:01 AM | VNDA
- New Insights into the Mechanism of Action of Antipsychotic Drugs
Mar 10, 2009 04:01 PM | VNDA
- Form 4 Feeney John Joseph For: Nov 06 (10K)
Nov 10, 2009 10:24 AM
- Form 4 TANG KEVIN C For: Oct 13 (10K)
Oct 15, 2009 07:59 PM
- Form 4 KARABELAS ARGERIS N For: Oct 13 (10K)
Oct 15, 2009 05:36 PM
- Form 4 Ramsay David Russ For: Oct 13 (10K)
Oct 15, 2009 05:32 PM
- Form 4 KARABELAS ARGERIS N For: Aug 27 (10K)
Aug 31, 2009 04:05 PM
- Form 4 PIEN HOWARD H For: Aug 27 (10K)
Aug 31, 2009 04:05 PM
- Form 4 Watkins Thomas For: Aug 27 (10K)
Aug 31, 2009 04:01 PM
- Form 4 Ramsay David Russ For: Aug 27 (10K)
Aug 31, 2009 04:00 PM
- Form 4 DUGAN RICHARD W For: Aug 27 (10K)
Aug 31, 2009 04:00 PM
- Form 4 Halak Brian K For: Aug 27 (10K)
Aug 28, 2009 07:32 PM
Analyst Ratings
Share Performance
|
Period
|
VNDA
|
Compare to S&P
|
| YTD |
1,956.00 %
|
1,601.59 %
|
| 4 Weeks |
-1.91 %
|
-2.97 %
|
| 12 Weeks |
-26.78 %
|
-30.97 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 39.13 %
|
|
EPS Growth in Last Year: 31.71 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
